BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10395176)

  • 21. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
    French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
    Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats.
    Murai T; Mori S; Kang JS; Morimura K; Wanibuchi H; Totsuka Y; Fukushima S
    Toxicol Pathol; 2008 Apr; 36(3):472-7. PubMed ID: 18413788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing.
    Venkatachalam S; Tyner SD; Pickering CR; Boley S; Recio L; French JE; Donehower LA
    Toxicol Pathol; 2001; 29 Suppl():147-54. PubMed ID: 11695551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of liver proliferative lesions in heterozygous p53 deficient CBA mice to various carcinogens.
    Uehara T; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Mitsumori K
    J Vet Med Sci; 2002 Jul; 64(7):551-6. PubMed ID: 12185306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogenic risk assessment of MeIQx and PhIP in a newborn mouse two-stage tumorigenesis assay.
    Miyauchi M; Nishikawa A; Furukawa F; Kasahara K; Nakamura H; Takahashi M; Hirose M
    Cancer Lett; 1999 Jul; 142(1):75-81. PubMed ID: 10424784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
    Hulla JE; French JE; Dunnick JK
    Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of susceptibility of heterozygous p53-knockout CBA and CIEA mice to phenolphthalein in a 6-month carcinogenicity study.
    Okamura M; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Usui T; Tamaoki N; Mitsumori K
    Toxicology; 2003 Mar; 185(1-2):17-22. PubMed ID: 12505441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Hirose M; Hasegawa R; Kimura J; Akagi K; Yoshida Y; Tanaka H; Miki T; Satoh T; Wakabayashi K; Ito N
    Carcinogenesis; 1995 Dec; 16(12):3049-55. PubMed ID: 8603484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular tumor induction in heterozygous p53-deficient CBA mice by a 26-week dietary administration of kojic acid.
    Takizawa T; Mitsumori K; Tamura T; Nasu M; Ueda M; Imai T; Hirose M
    Toxicol Sci; 2003 Jun; 73(2):287-93. PubMed ID: 12700405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53+/- hemizygous knockout mouse: overview of available data.
    Storer RD; French JE; Haseman J; Hajian G; LeGrand EK; Long GG; Mixson LA; Ochoa R; Sagartz JE; Soper KA
    Toxicol Pathol; 2001; 29 Suppl():30-50. PubMed ID: 11695560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
    Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacI transgenic (Big Blue) mice.
    Itoh T; Suzuki T; Nishikawa A; Furukawa F; Takahashi M; Xue W; Sofuni T; Hayashi M
    Mutat Res; 2000 Jun; 468(1):19-25. PubMed ID: 10863154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment.
    Nishikawa A; Imazawa T; Kuroiwa Y; Kitamura Y; Kanki K; Ishii Y; Umemura T; Hirose M
    Toxicol Sci; 2005 Apr; 84(2):243-8. PubMed ID: 15635146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice.
    Salim EI; Wanibuchi H; Morimura K; Wei M; Mitsuhashi M; Yoshida K; Endo G; Fukushima S
    Carcinogenesis; 2003 Feb; 24(2):335-42. PubMed ID: 12584185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement by cigarette smoke exposure of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis in close association with elevation of hepatic CYP1A2.
    Nishikawa A; Furukawa F; Miyauchi M; Son HY; Okazaki K; Koide A; Mori Y; Hirose M
    Jpn J Cancer Res; 2002 Jan; 93(1):24-31. PubMed ID: 11802804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic administration of low doses of 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline on glutathione S-transferase placental form-positive foci development in the livers of rats fed a choline-deficient diet.
    Sone H; Wakabayashi K; Kushida H; Ochiai M; Sugimura T; Nagao M
    Jpn J Cancer Res; 1993 Aug; 84(8):859-64. PubMed ID: 8407550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
    French J; Storer RD; Donehower LA
    Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ-dependent susceptibility of p53 knockout mice to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).
    Hirata A; Tsukamoto T; Yamamoto M; Takasu S; Sakai H; Ban H; Yanai T; Masegi T; Donehower LA; Tatematsu M
    Cancer Sci; 2007 Aug; 98(8):1164-73. PubMed ID: 17532756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.